SCHEMBL21292812

SCHEMBL21292812

O=C(NN=Cc1cc([N+](=O)[O-])ccc1O)c1cccc(O)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DUSP3 P51452 1/20 0.71
PTPN5 P54829 1/20 0.71
PTPN11 Q06124 1/20 0.71
MAPT P10636 8/20 0.70
KDM4E B2RXH2 7/20 0.70
TDP1 Q9NUW8 4/20 0.70
PHGDH O43175 2/20 0.70
ALDH1A1 P00352 2/20 0.70
L3MBTL1 Q9Y468 1/20 0.70
MEN1 O00255 8/20 0.70
KMT2A Q03164 8/20 0.70
NPC1 O15118 3/20 0.70
HTT P42858 2/20 0.66
LMNA P02545 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
NCOA1 Q15788 1/20 0.65
NPSR1 Q6W5P4 1/20 0.63
POLB P06746 2/20 0.62
CCR6 P51684 1/20 0.60
MAPK1 P28482 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21292811 1.00 DUSP3 (0.71) DUSP3PTPN5PTPN11MAPTKDM4E
SCHEMBL21292850 0.93 DUSP3 (0.82) DUSP3PTPN5PTPN11MAPTKDM4E
SCHEMBL21292847 0.93 DUSP3 (0.82) DUSP3PTPN5PTPN11MAPTKDM4E
SCHEMBL683798 0.89 KDM4E (0.78) DUSP3PTPN5PTPN11MAPTKDM4E
SCHEMBL21292702 0.89 DUSP3 (0.69) DUSP3PTPN5PTPN11MAPTKDM4E
SCHEMBL21292799 0.89 MEN1 (0.86) DUSP3PTPN5PTPN11MAPTKDM4E
SCHEMBL21292801 0.89 MEN1 (0.86) DUSP3PTPN5PTPN11MAPTKDM4E
SCHEMBL21292701 0.89 DUSP3 (0.69) DUSP3PTPN5PTPN11MAPTKDM4E
SCHEMBL12387919 0.87 PHGDH (0.75) DUSP3PTPN5PTPN11MAPTKDM4E
SCHEMBL21292819 0.87 PHGDH (0.79) DUSP3PTPN5PTPN11MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD DUSP3 129/4885PTPN5 909/4885PTPN11 1140/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD DUSP3 129/4885PTPN5 909/4885PTPN11 1140/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD DUSP3 129/4885PTPN5 909/4885PTPN11 1140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.